Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Net Debt Over TimeNormalizing
Percentile Rank33
Studio
Year-over-Year Change

Total debt minus cash and cash equivalents

Percentile
P33
Within normal range
vs 5Y Ago
-3.5x
Contraction
Streak
1 yr
Consecutive growthNormalizing
PeriodValueYoY Change
2025$-90.69M+50.0%
2024$-181.54M-121.2%
2023$-82.06M-937.3%
2022$-7.91M+97.7%
2021$-346.07M-1427.7%
2020$26.07M+596.9%
2019$-5.25M-